272 related articles for article (PubMed ID: 20431283)
1. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.
Ionita MG; Arslan F; de Kleijn DP; Pasterkamp G
J Innate Immun; 2010; 2(4):307-15. PubMed ID: 20431283
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic role of toll-like receptor modification in cardiovascular dysfunction.
Navi A; Patel H; Shaw S; Baker D; Tsui J
Vascul Pharmacol; 2013 Mar; 58(3):231-9. PubMed ID: 23070056
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors: emerging concepts in kidney disease.
Anders HJ; Schlöndorff D
Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
Frantz S; Ertl G; Bauersachs J
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
[TBL] [Abstract][Full Text] [Related]
5. The significance of toll-like receptors in human diseases.
Montero Vega MT; de Andrés Martín A
Allergol Immunopathol (Madr); 2009; 37(5):252-63. PubMed ID: 19853360
[TBL] [Abstract][Full Text] [Related]
6. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.
Pasterkamp G; Van Keulen JK; De Kleijn DP
Eur J Clin Invest; 2004 May; 34(5):328-34. PubMed ID: 15147329
[TBL] [Abstract][Full Text] [Related]
7. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
Cole JE; Mitra AT; Monaco C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors, endogenous ligands, and systemic autoimmune disease.
Rifkin IR; Leadbetter EA; Busconi L; Viglianti G; Marshak-Rothstein A
Immunol Rev; 2005 Apr; 204():27-42. PubMed ID: 15790348
[TBL] [Abstract][Full Text] [Related]
9. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors and adaptor molecules in liver disease: update.
Seki E; Brenner DA
Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors in inflammation, infection and cancer.
Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
[TBL] [Abstract][Full Text] [Related]
12. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
13. TLRs and chronic inflammation.
Ospelt C; Gay S
Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles of Toll-like receptor signaling in atherosclerosis.
Björkbacka H
Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors in ischemia-reperfusion injury.
Arumugam TV; Okun E; Tang SC; Thundyil J; Taylor SM; Woodruff TM
Shock; 2009 Jul; 32(1):4-16. PubMed ID: 19008778
[TBL] [Abstract][Full Text] [Related]
17. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors.
Albiger B; Dahlberg S; Henriques-Normark B; Normark S
J Intern Med; 2007 Jun; 261(6):511-28. PubMed ID: 17547708
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors, inflammation and cancer.
Tsan MF
Semin Cancer Biol; 2006 Feb; 16(1):32-7. PubMed ID: 16153858
[TBL] [Abstract][Full Text] [Related]
19. The role of toll-like receptors in chronic inflammation.
Drexler SK; Foxwell BM
Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
[TBL] [Abstract][Full Text] [Related]
20. Immune regulatory cells: circulating biomarker factories in cardiovascular disease.
Pasterkamp G; Versteeg D; de Kleijn DP
Clin Sci (Lond); 2008 Aug; 115(4):129-31. PubMed ID: 18384292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
